Latest filing published 13 Sept 2012 for AtriCure, Inc., €87k.
Insider track record
No signal scores available.
Closed purchases
Based on 16 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -69.5%Entry US$11.55 · Close at T+365 US$3.52
- -69.5%Entry US$11.00 · Close at T+365 US$3.35
- -68.7%Entry US$10.70 · Close at T+365 US$3.35
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David J. Drachman: trading record in brief
David J. Drachman discloses dealings in AtriCure, Inc. to SEC (Form 4). In total, 63 filings cover trades dated from 10 June 2008 to 12 September 2012.
The open-market side counts 17 purchases for €57k alongside 21 sales for €2.9M. Taken together, the sales exceed the purchases by €2.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 14 share grants and 11 option exercises. 2012 to date brings no purchases and 13 sales.
A typical purchase (the median) is worth €2,655. For 16 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -7.6%. These figures describe past trades and do not predict future prices.
The newest entry dates from 13 September 2012: an option exercise of €87k, in AtriCure, Inc. The most recent open-market purchase was published on 16 June 2008, 6,719 days ago. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David J. Drachman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$5.60Common StockSEC:0001181431-12-050310:0
- 20,000 shares@ US$7.04Common StockSEC:0001181431-12-050310:1
- 50,000 shares@ US$6.55Common StockSEC:0001181431-12-049290:0
- 180,583 shares@ US$6.53Common StockSEC:0001181431-12-049290:1
- 8,400 shares@ US$6.80Common StockSEC:0001181431-12-049290:2
- 50,000 shares@ US$7.45Common StockSEC:0001181431-12-046149:0
- 24,000 shares@ US$7.22Common StockSEC:0001181431-12-046149:1
- 2,500 shares@ US$7.03Common StockSEC:0001181431-12-046149:2
- 8,740 shares@ US$8.43Common StockSEC:0001181431-12-042812:0
- 24,553 shares@ US$1.33Common StockSEC:0001181431-12-032215:0
- 12,755 shares@ US$8.13Common StockSEC:0001181431-12-032215:1
- 5,343 shares@ US$1.33Common StockSEC:0001181431-12-031766:0
- 5,343 shares@ US$8.19Common StockSEC:0001181431-12-031766:1
- 33,841 shares@ US$8.24Common StockSEC:0001181431-12-031766:2
- 18,575 shares@ US$1.33Common StockSEC:0001181431-12-029264:0
- 18,575 shares@ US$9.10Common StockSEC:0001181431-12-029264:1
- 2,900 shares@ US$1.33Common StockSEC:0001181431-12-029264:2
- 2,900 shares@ US$9.06Common StockSEC:0001181431-12-029264:3
- 1,586 shares@ US$1.33Common StockSEC:0001181431-12-029264:4
- 1,586 shares@ US$9.04Common StockSEC:0001181431-12-029264:5
- 87,160 shares@ US$1.33Common StockSEC:0001181431-12-029264:6
- 2,340 shares@ US$9.95Common StockSEC:0001181431-12-010287:0
- 36,000 shares0Common StockSEC:0001181431-12-009400:0
- 8,006 shares@ US$11.05Common StockSEC:0001181431-12-007728:0
- 6,240 shares@ US$12.17Common StockSEC:0001181431-11-043178:0
25 of 62 declarations
